Quantitative, longitudinal measurements of response to immunotherapy for glioblastoma using multiparametric MRI in a long-term survivor treated with autologous tumor lysate–loaded dendritic cell vaccine: an illustrative case
BACKGROUND Neurosurgeons are in the forefront of developing clinical trials that harness the immune system to combat glioblastoma. Autologous tumor lysate–loaded dendritic cell vaccine (DCVax-L) is a novel immunotherapy for glioblastoma. An unmet need is to develop a sensitive, specific, feasible, clinically relevant,...
Archith Rajan, Steven Brem, Daniel Gewolb et al.
· Journal of Neurosurgery Case... · 0 citations